Rigel Pharmaceuticals Inc (RIGL)
SG&A Expense Growth
2.51%
Fiscal year · Period ending:
RIGL SG&A Expense Growth
Latest reported2.51%period ending
Latest reported2.51%period ending
RIGL FY SG&A Growth (YoY) (0.00% → 2.51%)
Latest values, visible window
High-resolution chart · PNG
RIGL sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 2.5128% | |
| 6.9207% | |
| -5.967% | |
| 22.3743% | |
| 19.9653% | |
| 2.6948% | |
| 6.5512% | |
| 85.0387% | |
| 80.9403% | |
| 17.375% | |
| -43.9896% | |
| 62.1609% | |
| -14.1669% | |
| 4.966% | |
| -13.9299% | |
| 20.9922% | |
| -22.7074% | |
| 24.266% | |
| 11.3083% | |
| 57.5504% | |
| -5.1006% | |
| 53.5039% | |
| -9.89% | |
| 18.9182% | |
| 18.8518% | |
| 69.2561% | |
| 0% |